1-(3-hydroxypropyl)-4-sulfanylidene-1,2,3,4,5,6,7,8-octahydroquinazolin-2-one, 95.0%, 250mg

2-Fluro-4-hydroxymethyl-3-methylpyridine, 95%, 100mg

2-(azetidin-3-yloxy)-6-(trifluoromethyl)pyridine, 95.0%, 1g

1-(5-Hydroxy-2-methylphenyl)ethanone, 95+%, 1g

1-Benzyl 4-(tert-butyl) (2R,5R)-2-(hydroxymethyl)-5-methylpiperazine-1,4-dicarboxylate, 98%, 1g

3-Fluoro-2-iodoaniline, 95.0%, 5g

2-Chloro-11-cyclopentyl-5-methyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one, 98%, 500mg

3-((Dimethylamino)methyl)aniline, 95.0%, 1g

ETHYL 3-HYDROXY-1-(4-(TRIFLUOROMETHYL)PHENYL)-1H-PYRAZOLE-4-CARBOXYLATE, 95.0%, 1g

C8 alkyne dCTP, min. 95%, 100 mM in water, 10 µl, plastic package.

1-(2-METHOXYETHYL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)INDOLINE, 95%, 100mg

4-amino-1-propyl-2-pyrrolidinone hydrochloride, 95.0%, 5g

5-Bromo-2-chloro-3-nitrobenzoic acid, 97%, 250mg